Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has ...
Evolving patient needs are driving new drug development paradigms. For complex genetic diseases, traditional therapies often fall short. Gene therapies and nucleic acid medicines offer a way to repair ...
Health and Me on MSN
Weight Loss Drugs Could Now Cut Stroke Risk, Finds Study
A new meta-analysis of 31 preclinical studies suggests GLP-1 drugs like semaglutide may reduce ischemic stroke severity in ...
News-Medical.Net on MSN
Research explores new solvent strategies to extend shelf life of injectable therapeutics
Kennesaw State University Assistant Professor of Chemistry and Biochemistry Mohammad Halim has received a three-year National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback